|
|
|
Volumn , Issue 171, 2006, Pages 267-286
|
|
Experimental therapy of genetic arrhythmias: disease-specific pharmacology.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
KCNH2 PROTEIN, HUMAN;
POTASSIUM CHANNEL HERG;
RYANODINE RECEPTOR;
SODIUM CHANNEL;
VOLTAGE GATED NA+ CHANNEL NA(V)1.5A;
VOLTAGE-GATED NA+ CHANNEL NA(V)1.5A;
ANIMAL;
CELL MEMBRANE POTENTIAL;
DEFIBRILLATOR;
DRUG EFFECT;
GENETICS;
HEART ARRHYTHMIA;
HUMAN;
LONG QT SYNDROME;
MUTATION;
REVIEW;
TACHYCARDIA;
ANIMALS;
ARRHYTHMIA;
DEFIBRILLATORS, IMPLANTABLE;
ETHER-A-GO-GO POTASSIUM CHANNELS;
HUMANS;
LONG QT SYNDROME;
MEMBRANE POTENTIALS;
MUTATION;
RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;
SODIUM CHANNELS;
TACHYCARDIA;
|
|
EID: 33646010644
PISSN: 01712004
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (84)
|
